Paris, France

Alexandre Edelman

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandre Edelman. Retrieved from https://idiyas.com/inventor/alexandre-edelman-tuqoeh3l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alexandre Edelman

Introduction

Alexandre Edelman is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of stable cell lines expressing the CFTR protein. His work has implications for understanding and treating cystic fibrosis.

Latest Patents

Edelman holds one patent titled "Stable cell lines expressing the CFTR protein or a mutant of this." This invention relates to a recombinant nucleic acid, characterized by its unique composition that facilitates the expression of the CFTR protein, which is crucial for various biological processes.

Career Highlights

Throughout his career, Edelman has worked with prestigious institutions such as Institut Curie and the Centre National De La Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading scientists and contribute to groundbreaking research.

Collaborations

Edelman has collaborated with esteemed colleagues, including Marie-Alyette Costa De Beauregard and Daniel Louvard. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Alexandre Edelman's work exemplifies the intersection of innovation and scientific research. His contributions to biotechnology continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…